细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2816人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979268, encodeId=ed1b19e926849, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=肿块型肝内单管细胞癌影像学, objectType=article, longId=293194, objectId=7212293194a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7212293194a7, replyNumber=0, likeNumber=51, createdTime=2022-01-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7212293194a7, moduleTitle=肿块型肝内单管细胞癌影像学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7212293194a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979199, encodeId=788b19e919913, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低, objectType=article, longId=217603, objectId=e41921e6037a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e41921e6037a, replyNumber=0, likeNumber=64, createdTime=2021-12-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e41921e6037a, moduleTitle=JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e41921e6037a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979125, encodeId=e41c19e91258b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：肝细胞癌伴有血管侵犯的患者手术切除和系统性治疗的疗效比较, objectType=article, longId=211546, objectId=4db8211546a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4db8211546a9, replyNumber=0, likeNumber=86, createdTime=2021-06-18, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4db8211546a9, moduleTitle=Liver Cancer：肝细胞癌伴有血管侵犯的患者手术切除和系统性治疗的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4db8211546a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979115, encodeId=5e5019e911512, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Radiology：对于cT1a肾细胞癌患者来说，有一种微创术式一定要知道！, objectType=article, longId=210837, objectId=843121083e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=843121083e43, replyNumber=0, likeNumber=53, createdTime=2021-05-31, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=843121083e43, moduleTitle=Radiology：对于cT1a肾细胞癌患者来说，有一种微创术式一定要知道！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=843121083e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979168, encodeId=8cdc19e9168a4, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：免疫检查点阻断治疗转移性肾细胞癌患者在临床结果方面的种族差异, objectType=article, longId=214306, objectId=a51f214306eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a51f214306eb, replyNumber=0, likeNumber=81, createdTime=2022-02-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a51f214306eb, moduleTitle=Front Oncol：免疫检查点阻断治疗转移性肾细胞癌患者在临床结果方面的种族差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a51f214306eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979244, encodeId=d4e219e9244cc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=人乳头瘤病毒感染基因型对妇女宫颈鳞状细胞癌和腺癌发病的影响, objectType=article, longId=221126, objectId=16bf2211261f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16bf2211261f, replyNumber=0, likeNumber=55, createdTime=2022-10-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16bf2211261f, moduleTitle=人乳头瘤病毒感染基因型对妇女宫颈鳞状细胞癌和腺癌发病的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16bf2211261f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979184, encodeId=449919e9184ae, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间, objectType=article, longId=216031, objectId=4df92160316b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4df92160316b, replyNumber=0, likeNumber=69, createdTime=2021-09-09, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4df92160316b, moduleTitle=Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4df92160316b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979290, encodeId=a66319e92900a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol Focus：Nivolumab单药治疗晚期肾细胞癌的疗效如何？, objectType=article, longId=295417, objectId=c68f29541e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68f29541e66, replyNumber=0, likeNumber=67, createdTime=2022-03-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68f29541e66, moduleTitle=Eur Urol Focus：Nivolumab单药治疗晚期肾细胞癌的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c68f29541e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979281, encodeId=87f319e92814d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancers：经动脉放射栓塞术(TARE)治疗不可切除肝细胞癌（HCC）安全有效, objectType=article, longId=294717, objectId=7d23294e17f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d23294e17f3, replyNumber=0, likeNumber=50, createdTime=2022-12-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d23294e17f3, moduleTitle=Cancers：经动脉放射栓塞术(TARE)治疗不可切除肝细胞癌（HCC）安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d23294e17f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979148, encodeId=8c0f19e91486a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ESMO Open：肿瘤突变负荷可预测口腔鳞状细胞癌患者预后, objectType=article, longId=212770, objectId=6d66212e701d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d66212e701d, replyNumber=0, likeNumber=63, createdTime=2021-11-22, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d66212e701d, moduleTitle=ESMO Open：肿瘤突变负荷可预测口腔鳞状细胞癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d66212e701d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979163, encodeId=9bb919e916320, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：肝切除术在伴有血管侵犯的肝细胞癌中的作用:来自西方国家的证据, objectType=article, longId=213962, objectId=b3ed2139621b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3ed2139621b, replyNumber=0, likeNumber=70, createdTime=2022-04-17, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3ed2139621b, moduleTitle=Liver Cancer：肝切除术在伴有血管侵犯的肝细胞癌中的作用:来自西方国家的证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3ed2139621b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979140, encodeId=7f7e19e91401d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancers：中性粒细胞/淋巴细胞比（NLR）是中期肝细胞癌（HCC）患者一线接受TACE治疗的预后指标。, objectType=article, longId=212415, objectId=b72721241538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b72721241538, replyNumber=0, likeNumber=84, createdTime=2021-11-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b72721241538, moduleTitle=Cancers：中性粒细胞/淋巴细胞比（NLR）是中期肝细胞癌（HCC）患者一线接受TACE治疗的预后指标。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b72721241538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979250, encodeId=580d19e925011, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：术前和术后应用nivolumab和lirilumab治疗局部区域复发的头颈部鳞状细胞癌(SCCHN)患者的疗效和安全性, objectType=article, longId=221221, objectId=5f1d221221eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f1d221221eb, replyNumber=0, likeNumber=64, createdTime=2022-05-18, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f1d221221eb, moduleTitle=Clin Cancer Res：术前和术后应用nivolumab和lirilumab治疗局部区域复发的头颈部鳞状细胞癌(SCCHN)患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f1d221221eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979185, encodeId=273e19e918526, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol：转移性肾细胞癌患者寡进展的立体定向放射治疗 , objectType=article, longId=216308, objectId=f8e521630891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e521630891, replyNumber=0, likeNumber=64, createdTime=2022-01-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e521630891, moduleTitle=Eur Urol：转移性肾细胞癌患者寡进展的立体定向放射治疗 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8e521630891)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979138, encodeId=339919e913842, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Hepatology：索拉非尼能降低肝细胞癌的肿瘤生长速度降低和肝功能的恶化, objectType=article, longId=212307, objectId=6a7721230e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a7721230e0e, replyNumber=0, likeNumber=84, createdTime=2021-06-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a7721230e0e, moduleTitle=J Hepatology：索拉非尼能降低肝细胞癌的肿瘤生长速度降低和肝功能的恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a7721230e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979112, encodeId=046019e91126f, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物, objectType=article, longId=210669, objectId=cd6f210669ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd6f210669ad, replyNumber=0, likeNumber=81, createdTime=2022-04-02, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd6f210669ad, moduleTitle=Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd6f210669ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979196, encodeId=7b4819e919641, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cnacer：BCLC 0/A期肝细胞癌根治性切除术后使用富马酸替诺福韦酯(TDF)预防复发优于恩替卡韦（ETV）, objectType=article, longId=217476, objectId=486321e47658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=486321e47658, replyNumber=0, likeNumber=59, createdTime=2022-07-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=486321e47658, moduleTitle=Liver Cnacer：BCLC 0/A期肝细胞癌根治性切除术后使用富马酸替诺福韦酯(TDF)预防复发优于恩替卡韦（ETV）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=486321e47658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979275, encodeId=c51919e9275f5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=European Radiology：混合性肝细胞癌-胆管癌的这些MRI表现提示了预后！, objectType=article, longId=294082, objectId=5b4c294082d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b4c294082d9, replyNumber=0, likeNumber=61, createdTime=2022-12-18, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b4c294082d9, moduleTitle=European Radiology：混合性肝细胞癌-胆管癌的这些MRI表现提示了预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b4c294082d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979122, encodeId=938d19e912210, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：探索可预测肝细胞癌对免疫检查点抑制剂响应的耗竭CD8 T细胞标志物, objectType=article, longId=211500, objectId=87b7211500a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87b7211500a5, replyNumber=0, likeNumber=109, createdTime=2022-01-09, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87b7211500a5, moduleTitle=Liver Cancer：探索可预测肝细胞癌对免疫检查点抑制剂响应的耗竭CD8 T细胞标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87b7211500a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979263, encodeId=66f019e926353, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Hepatol: Atezolizumab联合贝伐珠单抗vs索拉非尼治疗不可切除肝细胞癌的疗效更新：IMbrave150, objectType=article, longId=292266, objectId=82df292266f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82df292266f0, replyNumber=0, likeNumber=73, createdTime=2022-11-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82df292266f0, moduleTitle=J Hepatol: Atezolizumab联合贝伐珠单抗vs索拉非尼治疗不可切除肝细胞癌的疗效更新：IMbrave150, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82df292266f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

肿块型肝内单管细胞癌影像学

2022-01-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JNCCN：头颈部鳞状细胞癌(HNSCC)患者术后放疗（PORT）延迟会导致复发率增高并且OS降低

2021-12-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：肝细胞癌伴有血管侵犯的患者手术切除和系统性治疗的疗效比较

2021-06-18

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Radiology：对于cT1a肾细胞癌患者来说，有一种微创术式一定要知道！

2021-05-31

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：免疫检查点阻断治疗转移性肾细胞癌患者在临床结果方面的种族差异

2022-02-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

人乳头瘤病毒感染基因型对妇女宫颈鳞状细胞癌和腺癌发病的影响

2022-10-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间

2021-09-09

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol Focus：Nivolumab单药治疗晚期肾细胞癌的疗效如何？

2022-03-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancers：经动脉放射栓塞术(TARE)治疗不可切除肝细胞癌（HCC）安全有效

2022-12-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ESMO Open：肿瘤突变负荷可预测口腔鳞状细胞癌患者预后

2021-11-22

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：肝切除术在伴有血管侵犯的肝细胞癌中的作用:来自西方国家的证据

2022-04-17

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancers：中性粒细胞/淋巴细胞比（NLR）是中期肝细胞癌（HCC）患者一线接受TACE治疗的预后指标。

2021-11-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：术前和术后应用nivolumab和lirilumab治疗局部区域复发的头颈部鳞状细胞癌(SCCHN)患者的疗效和安全性

2022-05-18

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol：转移性肾细胞癌患者寡进展的立体定向放射治疗

2022-01-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Hepatology：索拉非尼能降低肝细胞癌的肿瘤生长速度降低和肝功能的恶化

2021-06-12

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物

2022-04-02

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cnacer：BCLC 0/A期肝细胞癌根治性切除术后使用富马酸替诺福韦酯(TDF)预防复发优于恩替卡韦（ETV）

2022-07-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

European Radiology：混合性肝细胞癌-胆管癌的这些MRI表现提示了预后！

2022-12-18

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：探索可预测肝细胞癌对免疫检查点抑制剂响应的耗竭CD8 T细胞标志物

2022-01-09

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Hepatol: Atezolizumab联合贝伐珠单抗vs索拉非尼治疗不可切除肝细胞癌的疗效更新：IMbrave150

2022-11-05

科室
- - 订阅+
  - 更多科室
工具
服务